{"id":"NCT03556358","sponsor":"Tanvex BioPharma USA, Inc.","briefTitle":"Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer","officialTitle":"A Randomized, Double-blind, Parallel Group, Phase III Trial to Compare the Efficacy, Safety, and Immunogenicity of TX05 With Herceptin® in Subjects With HER2 Positive Early Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-06-28","primaryCompletion":"2020-11-27","completion":"2021-02-04","firstPosted":"2018-06-14","resultsPosted":"2022-01-14","lastUpdate":"2022-01-14"},"enrollment":809,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer","Breast Neoplasms","HER2-positive Breast Cancer","Stage II Breast Cancer","Stage IIIA Breast Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"TX05 (trastuzumab)","otherNames":[]},{"type":"BIOLOGICAL","name":"Herceptin®","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Ribotax"]},{"type":"DRUG","name":"Epirubicin","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]}],"arms":[{"label":"TX05 (trastuzumab)","type":"EXPERIMENTAL"},{"label":"Herceptin®","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase III, double-blind, randomized, multicenter study to compare the efficacy and to evaluate the safety and immunogenicity of TX05 (trastuzumab) with Herceptin® in subjects with HER2 positive early breast cancer.","primaryOutcome":{"measure":"Proportion of Subjects in Each Treatment Arm Who Achieve Pathologic Complete Response (pCR)","timeFrame":"3-7 weeks following last dose of study treatment","effectByArm":[{"arm":"TX05 (Trastuzumab)","deltaMin":172,"sd":null},{"arm":"Herceptin®","deltaMin":185,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":14},"locations":{"siteCount":146,"countries":["Belarus","Chile","Georgia","Hungary","India","Mexico","Peru","Philippines","Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":394},"commonTop":["Arthralgia","Myalgia","Asthenia","Peripheral Sensory Neuropathy","Nausea"]}}